LEHI, Utah and LOUISVILLE, Ky., Feb. 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it was named by Black Book Market Research™ as the industry's leading AI-powered software platform. Waystar earned #1 rankings in eight key categories, including claim accuracy, operational efficiency, reduction in administrative burden, and patient engagement. The independent survey assessed AI-powered revenue cycle management solutions from 80 vendors, gathering insights from more than 1,300 healthcare executives and technology decision-makers.
Waystar ranked as the #1 healthcare payments solution in eight out of 18 AI categories — more than any other vendor, none of which secured more than one top ranking. As Black Book™ highlighted in its report, "Waystar showed dominant performance in claims submission, denial reduction, and reimbursement turnaround time, cementing its role as a leader in financial accuracy and efficiency."
"We are grateful for the trust healthcare providers place in our AI-powered software platform, which has been central to our innovation strategy for nearly a decade," said Matt Hawkins, Chief Executive Officer of Waystar. "In January, we launched Waystar AltitudeAI™, a comprehensive set of AI capabilities for providers, including AltitudeCreate™, a first-of-its-kind generative AI capability for appealing denied claims. We continue to deliver on our vision of AI-powered software that drives productivity and accuracy and advances our mission."
Surveyed industry leaders recognized the impact of Waystar's AI, automation, and predictive analytics solutions across multiple points of the revenue cycle.
Claim, denial, and payer payments management: Waystar secured the #1 ranking in numerous AI-driven financial and payment management categories, including reduction in claim rejection and denial rates, increase in clean claim submission rates, time savings in claim resubmission and appeals resolution, and improvement in overall claims reimbursement turnaround time. Black Book™ highlighted:
Patient collections and engagement: Waystar earned the top recognition in upfront patient payment collection rates as well as automated patient payment processing and engagement. According to the report:
Finance and IT professionals prioritize AI adoption, recognizing its ability to automate manual work and reduce administrative burden across denial reduction, collections, and patient payment engagement. Purpose-built to eliminate inefficiencies, Waystar's modern, cloud-based platform leverages AI-powered capabilities to streamline end-to-end healthcare payments, delivering continuous enhancements that drive efficiency, accuracy, and sustainable return on investment.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar's enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
Media Contact
Kristin Lee
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact
Sandy Draper
This email address is being protected from spambots. You need JavaScript enabled to view it.
502-238-9511
Last Trade: | US$37.64 |
Daily Change: | -0.25 -0.66 |
Daily Volume: | 991,631 |
Market Cap: | US$6.510B |
April 30, 2025 April 30, 2025 April 23, 2025 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load